Not every BP medicine is heart-friendly
The reviewed data show that maternal exposure to GLP-1 agonists causes reduced embryonic-fetal survival, increases in major congenital anomalies, reduced fetal weight/growth, retardation of ossification, irregular ossification and skeletal variants in mice, rats and rabbits
Their ability to improve metabolic health, reduce systemic inflammation, and lower surgical complication rates makes them valuable in optimizing patient outcomes
At Colair, we take the time to understand your goals, your timeline, and what side effects you may be experiencing from your GLP-1 medications so we can recommend the right combination of skin care treatments for you
Lifestyle programs such as diet, exercise, and behaviour change, remain foundational, and bariatric surgery has been the most reliable way to produce large, durable weight loss